הלוואות ואשראי לטווח ארוך של החברה FSD Pharma Inc. (HUGE)

FSD Pharma Inc. (HUGE) focuses on developing high-precision drugs to combat severe inflammation and neuronal degeneration. The market price on the GURU.Markets platform, where long-term debt stands at 0.00, as confirmed by this chart, is complemented by the stability of a tight-knit circle of leading neurobiologists. Business development relies on a strategic alliance with biotech centers to identify new therapeutic approaches in the field of neurology.

The indicator aggregates all confirmed credit obligations with maturities exceeding twelve months. The calculation is based on verified reporting data, excluding subjective estimates. The long-term debt dynamics for FSD Pharma Inc. (HUGE) reflect the actual volume of raised capital. This metric is critical for FSD Pharma Inc. during a shift in R&D focus, as it demonstrates the startup's financial stability during the transition to clinical trials for neurological drugs.